Celanese NYSE: CE executives said the company expects supply-chain conditions in its Acetyl Chain business to moderate during the second half of 2026, while cost actions, targeted growth initiatives and free-cash-flow generation remain central to its strategy.
Celanese Corporation (CE) Q2 2026 Earnings Call Transcript
CE beats Q2 earnings and sales estimates as strong pricing, commercial execution and medical and electronics momentum lift results.
| Chemicals Industry | Materials Sector | Scott A. Richardson CEO | XETRA Exchange | US1508701034 ISIN |
| US Country | 11,434 Employees | 28 Jul 2026 Last Dividend | - Last Split | - IPO Date |
Celanese Corporation, founded in 1918 and headquartered in Irving, Texas, stands as a global leader in the chemical and specialty materials sector. With operations spreading across the United States and international markets, Celanese is renowned for manufacturing and selling high-performance engineered polymers. The company operates through two primary segments: Engineered Materials and Acetyl Chain, each focusing on the development and supply of specialty polymers and acetyl products, respectively. These products find applications in a diverse range of industries including automotive, medical, consumer electronics, paints, adhesives, pharmaceuticals, and many others, showcasing the company’s extensive footprint in the realm of chemical and specialty materials.